261 related articles for article (PubMed ID: 2841448)
1. Inhibition of acid secretion in guinea pigs by tricyclic antidepressants: comparison with ranitidine and omeprazole.
Batzri S; Brugada O; Harmon JW; Rich NM
J Pharmacol Exp Ther; 1988 Aug; 246(2):493-9. PubMed ID: 2841448
[TBL] [Abstract][Full Text] [Related]
2. Comparison of the effect of omeprazole--a substituted benzimidazole--and ranitidine--a potent H2-receptor antagonist--on histamine-induced gastric acid secretion and the ultrastructure of canine parietal cells.
Stachura J; Konturek SJ; Cieszkowsky M; Dabroś W; Zakrzewska J; Konturek J
Hepatogastroenterology; 1983 Oct; 30(5):205-10. PubMed ID: 6315556
[TBL] [Abstract][Full Text] [Related]
3. The mechanism of action of omeprazole--a survey of its inhibitory actions in vitro.
Wallmark B; Lorentzon P; Larsson H
Scand J Gastroenterol Suppl; 1985; 108():37-51. PubMed ID: 2988109
[TBL] [Abstract][Full Text] [Related]
4. Pharmacological regulation of gastric acid secretion in the apical membrane of parietal cells; a new target for antisecretory drugs.
Okabe S; Shimosako K; Amagase K
J Physiol Pharmacol; 2001 Dec; 52(4 Pt 1):639-56. PubMed ID: 11787764
[TBL] [Abstract][Full Text] [Related]
5. Antisecretory and antiulcer activities of a novel proton pump inhibitor AG-1749 in dogs and rats.
Satoh H; Inatomi N; Nagaya H; Inada I; Nohara A; Nakamura N; Maki Y
J Pharmacol Exp Ther; 1989 Feb; 248(2):806-15. PubMed ID: 2537418
[TBL] [Abstract][Full Text] [Related]
6. Biological basis of omeprazole therapy.
Sachs G; Wallmark B
J Gastroenterol Hepatol; 1989; 4 Suppl 2():7-18. PubMed ID: 2562365
[TBL] [Abstract][Full Text] [Related]
7. Control of gastric acid secretion. Histamine H2-receptor antagonists and H+K(+)-ATPase inhibitors.
Shamburek RD; Schubert ML
Gastroenterol Clin North Am; 1992 Sep; 21(3):527-50. PubMed ID: 1355465
[TBL] [Abstract][Full Text] [Related]
8. The effect of secretagogue selection on potency determinations for gastric acid antisecretory agents.
Palumbo GJ; Nielsen ST
Methods Find Exp Clin Pharmacol; 1988 Mar; 10(3):151-5. PubMed ID: 2898575
[TBL] [Abstract][Full Text] [Related]
9. Pharmacology of ORF 17578, a new histamine H2-receptor antagonist: comparison with cimetidine and ranitidine.
Katz LB; Scott CK; Shriver DA
J Pharmacol Exp Ther; 1986 May; 237(2):404-10. PubMed ID: 2871172
[TBL] [Abstract][Full Text] [Related]
10. Isolated gastric mucosa: an early approach to the study of the mechanism of action of gastric antisecretory agents.
Colombo M; Fort M; Farré AJ
Methods Find Exp Clin Pharmacol; 1989 Oct; 11(10):621-34. PubMed ID: 2573753
[TBL] [Abstract][Full Text] [Related]
11. The gastric H+,K+-ATPase: the site of action of omeprazole.
Sachs G; Wallmark B
Scand J Gastroenterol Suppl; 1989; 166():3-11. PubMed ID: 2557669
[TBL] [Abstract][Full Text] [Related]
12. Effects of ORF 17583, other histamine H2-receptor antagonists and omeprazole on gastric acid secretory states in rats and dogs.
Katz LB; Tobia AJ; Shriver DA
J Pharmacol Exp Ther; 1987 Aug; 242(2):437-42. PubMed ID: 2886642
[TBL] [Abstract][Full Text] [Related]
13. Cyclo-oxygenase-1 inhibition increases acid secretion by modulating H+,K+-ATPase expression and activation in rabbit parietal cells.
Nandi J; Das PK; Zinkievich JM; Baltodano JD; Levine RA
Clin Exp Pharmacol Physiol; 2009 Feb; 36(2):127-34. PubMed ID: 18759857
[TBL] [Abstract][Full Text] [Related]
14. Effects of omeprazole and ranitidine on gastric acid secretion, blood gastrin levels and [3H]-thymidine incorporation in the oxyntic mucosa from dogs and rats.
Ryberg B; Mattsson H; Carlsson E
Digestion; 1988; 39(2):91-9. PubMed ID: 3410171
[TBL] [Abstract][Full Text] [Related]
15. Reversible inhibition of rat gastric H+/K+-ATPase by T-330, 2-[2-dimethylaminobenzyl)sulfinyl]-1-(3-methylpyridine-2-yl)imidazole.
Kinoshita M; Saito N; Noto T; Tamaki H
J Pharmacol Exp Ther; 1996 Apr; 277(1):28-33. PubMed ID: 8613931
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of gastric H,K-ATPase activity and gastric epithelial cell IL-8 secretion by the pyrrolizine derivative ML 3000.
Smolka AJ; Goldenring JR; Gupta S; Hammond CE
BMC Gastroenterol; 2004 Feb; 4():4. PubMed ID: 15028114
[TBL] [Abstract][Full Text] [Related]
17. Omeprazole: mode of action and effect on acid secretion in animals.
Wallmark B
Methods Find Exp Clin Pharmacol; 1989; 11 Suppl 1():101-6. PubMed ID: 2657278
[TBL] [Abstract][Full Text] [Related]
18. Time course of inhibition of gastric acid secretion by omeprazole and ranitidine in gastric fistula rats.
Seensalu R; Girma K; Romell B; Nilsson G
Eur J Pharmacol; 1990 May; 180(1):145-52. PubMed ID: 2364999
[TBL] [Abstract][Full Text] [Related]
19. Pharmacological comparison of ORF 17910, a potent, long-acting histamine H2-receptor antagonist, to cimetidine and ranitidine.
Katz LB; Scott CK; Shriver DA
J Pharmacol Exp Ther; 1986 Aug; 238(2):587-93. PubMed ID: 2874214
[TBL] [Abstract][Full Text] [Related]
20. Possible mechanism for the inhibition of acid formation by the proton pump inhibitor AG-1749 in isolated canine parietal cells.
Nagaya H; Satoh H; Maki Y
J Pharmacol Exp Ther; 1990 Mar; 252(3):1289-95. PubMed ID: 2156997
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
